Indian-origin biotech entrepreneur raises $1.1 billion
A US-based biotech company ‘Roivant Sciences’ founded by an Indian-origin entrepreneur Vivek Ramaswamy has raised $1.1bn from SoftBank and other investors, one of the largest fundings in the life science sector. Roivant Sciences, which has 5 subsidiaries (Axovant, Myovant, Enzyvant, Dermavant, and Urovant ), was established in May 2014.